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The technology of cloning functional T  cell subsets in vitro has proved to be 
a powerful tool in studies of cellular immune response to conventional as well as 
cell surface-associated antigens. Considering the scope of the technology in clonal 
analysis of cytotoxic immune response against autologous tumor cells, this study 
was undertaken to examine whether cytotoxic T  lymphocyte (CTL) clones can 
be generated against autologous tumor cells in a human melanoma system and, 
if feasible, to employ such clones in assays designed to determine putative cell- 
mediated  and/or  circulating  serum  factor(s)  capable  of modulating  cytotoxic 
function of such clones.  We  report in  this communication  that  it is  feasible to 
generate  CTL  clones  with  specificity  directed  toward  an  autologous  human 
melanoma cell line, and show that the cytotoxicity of the CTL clone against the 
autologous melanoma  cells could not be modulated in  microcytotoxicity assays 
in the presence of unfractionated autologous lymphocytes or serum. 
Materials and  Methods 
Target Cells.  The human tumor cell line VIP was derived from a primary melanoma. 
This cell line grew as an adherent culture, was not contact inhibited, expressed melano- 
somes, did not contain any virus-like particles, and produced tumors histologically con- 
sistent with melanoma in nude mice when injected subcutaneously at ~ 0.5-1  x  106 cells 
inocula. The VIP-F:T line was originally established  from normal skin from the same 
patient (derived from a site distant from the primary site). After growing well for several 
months as contact-inhibited fibroblasts, the VIP-F:T culture developed features charac- 
teristic of in vitro transformation (disorganization in the arrangement of the ceils, fusion 
between cells,  cell surface shedding, and marked tendency for anchorage-independent 
growth).  Electron microscopic examination showed unidentifiable cytoplasmic granules 
without suggestion of definitive viral structures and no evidence of virus budding. When 
injected subcutaneously in nude mice at 0.5-1 x  106 cell inocula, these cells also produced 
a tumor whose morphology was consistent with that of a sarcoma. These two cell lines, 
and several other cell lines grown in our laboratory or obtained from other laboratories, 
were used. Tissue culture technique has been published previously (1). 
Effector Cells.  Blood  mononuclear  cells  (referred to  henceforth  as  unfractionated 
lymphocyte [Ly]) were isolated from peripheral blood on  Ficoll-Hypaque gradient (1). 
Monocytes/macrophages were removed whenever needed by adherence on plastic flasks 
for 2 h and/or by nylon column incubation (1-3). 
Phenotypic Analysis.  Phenotypic analyses of Ly were performed by immunofluorescence 
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technique using monoclonal reagents (monoclonal antibodies OKT3, OKT4, OKT8, and 
M-1 were obtained from Ortho Pharmaceutical Corp., Raritan, NJ; monoclonal antibody 
HNK-1 [Leu-7] was obtained from Becton, Dickinson & Co., Sunnyvale, CA). The stained 
cells were analyzed either in a  fluorescence-activated cell sorter (FACS  IV; B-D FACS 
Systems, Sunnyvale, CA) or examined under a microscope. 
Interleukin  2 (IL~2).  IL-2 was generated in  mixed Ly culture (MLC) using the basic 
method of Mier and Gallo (4) with some modifications. Multiple allogeneic mononuclear 
cell fractions isolated on FicolI-Hypaque gradients and spleen cells from a  single donor 
were used in the MLC. The cultures were carried out at a concentration of 1 ×  106 cells/ 
ml in 500-1,000  ml vol in RPMI  1640,  10% human albumin, and  10 #g/ml phytohem- 
agglutinin-P (PHA-P; Difco Laboratories, Detroit, MI) at 37 °C in 50% CO2 for 72 h. The 
cell-free supernatants were concentrated down to  1/5 vol by absorption in Aquacide II 
(Calbiochem-Behring Corporation, San Diego, CA) in 3,500  tool wt dialysis Spectrapor 
membrane  (Spectran  Medical  Industries,  Inc.,  Los  Angeles,  CA).  The  concentrated 
supernatant (referred to henceforth as IL-2) was filtered through 0.22 ~m Millex filters 
(Millipore Corp., Bedford, MA), and aliquots were stored frozen at -20°C. 
Generation oJCytotoxic Lymphocytes (CL).  CL were generated against the VIP melanoma 
cells in a one-way mixed lymphocyte-tumor cell interaction (MLTI). ~2 ×  107 mononu- 
clear cells isolated on Ficoll-Hypaque gradient were co-cultured with 0.5 ×  105 VIP ceils 
(irradiated with 4,500 rad from a cesium source), seeded the day before in 5 ml of Ham's 
F-10 medium containing  10% fetal calf serum (FCS) and antibiotics. On the  3rd d, an 
additional 3 ml of medium containing 10% FCS and antibiotics were added. On the 7th 
d,  the sensitized lymphocytes were washed,  refractionated on FicolI-Hypaque gradient, 
and cultured in Ham's F-10 medium containing 10% FCS, antibiotics, and 10% IL-2. The 
cultures expanded rapidly thereafter and were fed with IL-2-containing medium three 
times a week. 
Generation of CL Clones.  Cloning of CL was performed by limiting dilution in 96-well 
microtiter plates (Costar, Cambridge, MA). Usually 200-300 wells were seeded. Each well 
was preseeded with  1 ×  105 irradiated (4,500 rad) allogeneic mononuclear cells derived 
from a pool of four normal volunteers. Thoroughly washed and vigorously suspended CL 
were counted several times before seeding at various cell numbers in  20%  IL-2. Wells 
were  checked  for  colonies  daily  from the  6th  d.  Each  well  was  fed  with  20%  IL-2- 
containing medium every 3rd d  thereafter. Growing colonies were transferred to a new 
96-well  plate and  expanded  serially until  5-10  wells  were  grown,  at  which  point  the 
colonies were pooled in 2-ml wells. Growing colonies were expanded serially thereafter at 
a cell density of "~3-5 ×  l0  b cells per 2-ml well.  Aliquots were frozen at -80°C in  10% 
DMSO and transferred to liquid nitrogen 24 h later. Colonies could be recovered without 
loss of function. Colonies maintained in continuous culture were restimulated every 2 wk 
with a  10-fold excess of irradiated allogeneic spleen cells and sensitizing autologous VIP 
melanoma cells.  The clones described in this communication have been propagated >2 
mo in culture. 
51  Cell-mediated Microcytotoxicity (CMC) Assay.  The basic  Cr-release assay (5)  was used. 
Briefly, thoroughly washed target cells were labeled with 0.1  ml of Na~ 5XCrO4 (1  mCi/ 
ml, specific activity 200 or more t~Ci/mg) in a 37 °C bath for 30 rain with periodic shaking. 
Thereafter, the cells were washed again, resuspended in  1 ml of medium, and placed in 
the same 37°C bath for another 30 rain. The cells were then washed five times in medium 
and counted. Cell concentration was adjusted and "~ 1,000-2,000 labeled target cells were 
seeded in V-shaped microwell plates (Costar) in 0.1  ml of complete medium. Effector cells 
at desired concentrations were added in 3-5 replicates at different effector/target (E/T) 
ratios. The plates were centrifuged at 200 g for 2 rain and incubated at 37°C for 4 h. To 
determine maximum release, 0.1  ml of 1% sodium dodecyl sulfate solution was added to 
the appropriate wells.  The plates were centrifuged again at 400 g  for 5  rain.  Aliquots 
containing 0.1  ml of samples were withdrawn  in  1 ml of Hydrofluor and  counted  for 
activity in  a  liquid  scintillation  counter  (Beckman  Instruments,  Inc.,  Palo  Alto,  CA). 
Percent specific lysis was determined by the following formula: [(experimental release - 
spontaneous release)/(maximum release -  spontaneous release)] x  100. 242  MUKHERJI  AND  MAcALISTER  BRIEF  DEFINITIVE  REPORT 
Results and Discussion 
Fig.  1 shows a  representative CMC assay with the unfractionated autologous 
Ly (macrophages removed by nylon column incubation) against the two autolo- 
gous cell lines and the natural killer (NK)-sensitive cell line K562. Little cytotoxic 
activity  was  detectable  with  the  unfractionated  Ly  against  the  transformed 
fibroblasts, and only minimal to modest levels of cytotoxicity were seen against 
the  melanoma cells.  The same  Ly were,  however,  quite cytotoxic against  the 
K562 cells. 
Table I shows the activities of the CL generated in vitro in MLTI against the 
VIP melanoma cells followed by expansion  in  IL-2  for 2  wk.  As can  be seen, 
marked cytotoxic activity was generated against the sensitizing autologous target. 
It  is  noteworthy  that  the  same  Ly  showed  statistically  significant  (although 
considerably  less)  activity against  the transformed  fibroblasts.  The  K562  cells 
and  another allogeneic  melanoma cell  line  were  lysed  with considerable  effi- 
ciency. In addition to these allogeneic cells, several other allogeneic targets were 
also  lysed  (individual  data  not  shown).  A  variety  of  cell-mediated  cytolytic 
phenomena, such as anomalous killing (6), lectin-activated cytolysis (7, 8), inter- 
feron-induced killing (9), or lymphokine-activated cytotoxicity (10), could explain 
this polyclonal generation of CL. 
CL generated against the autologous VIP melanoma cells and expanded in IL- 
2 for 2 wk were cloned by limiting dilution technique. Fig. 2 shows one of several 
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FIGURE  1.  Cytotoxicity of unfractionated Ly against the two autologous targets and K562 
cells. Each point represents percent specific lysis calculated from the mean of three replicate 
determinations. 
TABLE  I 
Cytotoxicity of Unfractionated CL Generated in Autologous MLTI 
against VIP Cells 
Percent specific lysis 
Target  E/T ratio 
12:1  25:1  50:1 
V1P  22*  34  58 (10)* 
VIP-F:T  13  17  25 (8) 
K562  14  27  36 (6) 
MG-E (allogeneic melanoma)  24  31  40 (9) 
* Data expressed as mean percent specific  lysis of StCr-labeled  target cells  above 
medium (spontaneous release). 
* Spontaneous release with individual targets. MUKHERJI  AND  MAcALISTER  BRIEF  DEFINITIVE  REPORT  243 
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FIGURE  2.  Data points with 0.5- and  1-cell wells are derived from  t00 wells each; 3-,  10-, 
and 25-cell wells are derived from 32 wells each. 
FIGURE 3.  Cytotoxicity of clones E.5 and 3:1 against the autologous targets. (&) E.5 against 
VIP; (A) E.5 against VIP-F:T; (0) 3:1 against VIP; (O) 3:1 against VIP-F:T. 
limiting dilution cloning experiments.  Several colonies were grown from wells 
seeded with 0.5-3 cells per well. Of these, two colonies (E.5, derived from a well 
seeded with 0.5 cells, and 3:1, derived from a  well seeded with 3 cells) proved 
phenotypically homogeneous (bearing  OKT8  phenotype exclusively) and  ex- 
pressed cytotoxicity selectively against the autologous target VIP cells only. Fig. 
3 shows the cytotoxicity of the colonies against the two autologous targets. Both 
colonies  were  highly  cytotoxic  against  the  VIP  melanoma  cells,  whereas  the 
transformed fibroblasts were not lysed. It is noteworthy that the parent CL line 
frona which these colonies were generated expressed statistically significant levels 
of cytotoxicity against the transformed fibroblasts (Table I). Detailed phenotypic 
analyses revealed no OKT4,  M-l, or HNK-t  phenotypes within either colony. 
Colony  E.5  was  99°~  positive  and  colony  3:1  was  98%  positive  for  OKT8 
phenotype. 
The range of cytotoxicity and the specificity screen of the colonies are shown 
in  Fig.  4.  The  activities  of both  colonies  were  restricted  to  the  autologous 
melanoma cells, and  the cytotoxic profile of the two colonies was remarkably 
identical.  Although colony 3:1  was derived from a  three cell-seeded well,  the 
phenotypic homogeneity and, most importantly, the selective cytotoxic activity 
of the  colony  (restricted  solely  to  the  sensitizing  autologous  melanoma  cells) 
suggested that it was quite possibly a  true clone. The phenotypic homogeneity 
and the highly selective cytotoxic activity of colony E.5 were also suggestive of a 
true clone. The target cell panel used in the specificity screen has been reasonably 
large  and  included  several  NK-sensitive  and  other  allogeneic  targets  against 
which  the  unfractionated  CL  showed  significant  cytotoxicity.  This  restricted 
expression  of cytotoxicity  therefore  argued  against  anomalous  killing,  lectin- 
dependent cytolysis, or lymphokine-mediated killing. Taking this into consider- 
ation, these two colonies will henceforth be referred to as clones. 
Presently, no conclusion can be drawn as to whether these two clones expressed 
any  fine specificity directed against a  putative tumor-associated antigen,  since 
the very nature of the tumor antigen remains unclear. Such a possibility, however, 244 
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FIGURE  4.  Range of cytotoxic activity of clones 3:1  (A) and E.5 (B).  In addition to the two 
autologous targets, the target panel consists of the following: K562 and MOLT4 (NK-sensitive 
targets); JS, MG-E, and MS (allogeneic melanoma cells); SK-BR3 (human breast cancer line); 
SAOS (human sarcoma line). E/T  ratios =  10:1. 
TABLE  II 
Cytotoxicity of Clone E.5 against VIP Cells in the Presence of 
Autologous Serum and Unfractionated Ly 
In the presence off  Percent specific lysis at E/T = 
10:1 
Medium alone  40* 
Autologous sermn*  38 
AB serum*  37 
Autologous Ly  ! 
Ly/E.5 =  1.25:1  41 
2.5:1  39 
5:1  43 
* Differences in percent specific  lysis were not statistically  significant  (Student's t 
test). Spontaneous release was 6%. 
* Autologous and AB-positive serum were added in 50% concentration. 
I Viability of the frozen cells was >95%. 
cannot be ruled out. Of the two clones, clone E.5  was expanded by repeated 
restimulation against irradiated VIP cells and allogeneic spleen cells. Experiments 
were therefore designed with this clone to search for putative autologous cell- 
or serum-mediated modulating factors. Table II shows the results of an experi- 
ment  carried  out  to  examine  the  effect  of the  unfractionated  lymphocytes 
(collected before surgical removal of the melanoma from the patient and kept 
frozen at -180°C) as well as to search for any circulating factor(s) in the serum 
potentially capable of modulating the cytotoxicity of the CTL clone. As can be 
seen, no abrogation of cytotoxicity was detected with the unfractionated Ly or 
with the autologous serum obtained at the same time. While it will not be possible 
to draw any conclusion as to whether or not the generation of cytotoxic immune 
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mechanism, this study clearly suggests that analysis of cellular immune response 
against autologous tumor might be feasible with autoreactive clones generated 
by in vitro cloning technology. 
Summary 
We investigated  the  feasibility of generating  cytotoxic T  cell  clones against 
autologous  human  melanoma  cells  using  a  melanoma  cell  line  (VIP)  and  a 
spontaneously transformed autologous fibroblast line (VIP-F:T). Cytotoxic lym- 
phocytes  (CL)  generated  against  the  VIP  melanoma  cells  in  one-way  mixed 
lymphocyte-tumor cell  interactions  were expanded  in  interleukin  2  for  2  wk. 
The expanded CL were cloned in limiting dilution.  Two phenotypically homo- 
geneous clones (3:1  and  E.5)  were  obtained  bearing  OKT3  phenotype.  Both 
clones expressed cytotoxicity selectively only against  the sensitizing autologous 
target VIP. Cytotoxicity assays performed with clone E.5 against the VIP target 
cells in the presence of autologous unfractionated lymphocytes or serum showed 
no modulation of autoreactivity of clone E.5. These results indicate that analysis 
of cellular  immune  response against  autologous  tumor  cells might  be feasible 
using autoreactive clones generated  by the currently available in vitro cloning 
technology. 
We thank Elizabeth Galusza for technical assistance and Donna Perleone for preparation 
of the manuscript. 
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